Business Description
IDEAYA Biosciences Inc
NAICS : 325412
SIC : 2834
ISIN : US45166A1025
Description
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 48.95 | |||||
| Equity-to-Asset | 0.95 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.09 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 23.7 | |||||
| Beneish M-Score | -4.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -19.8 | |||||
| 3-Year EBITDA Growth Rate | -18.2 | |||||
| 3-Year EPS without NRI Growth Rate | -11.9 | |||||
| 3-Year Book Growth Rate | 12.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -11.93 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.36 | |||||
| 9-Day RSI | 42.29 | |||||
| 14-Day RSI | 42.05 | |||||
| 6-1 Month Momentum % | -19.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 22.93 | |||||
| Quick Ratio | 22.93 | |||||
| Cash Ratio | 22.63 | |||||
| Days Sales Outstanding | 125.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -30.1 | |||||
| Shareholder Yield % | -33.23 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -5730.6 | |||||
| Net Margin % | -4579.42 | |||||
| FCF Margin % | -3901.42 | |||||
| ROE % | -21.5 | |||||
| ROA % | -20.61 | |||||
| ROIC % | -112.96 | |||||
| ROC (Joel Greenblatt) % | -1882.83 | |||||
| ROCE % | -26.76 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 456 | |||||
| PB Ratio | 2 | |||||
| Price-to-Tangible-Book | 2 | |||||
| EV-to-EBIT | -6.51 | |||||
| EV-to-Forward-EBIT | -5.1 | |||||
| EV-to-EBITDA | -6.64 | |||||
| EV-to-Forward-EBITDA | -5.17 | |||||
| EV-to-Revenue | 373.16 | |||||
| EV-to-Forward-Revenue | 59.4 | |||||
| EV-to-FCF | -9.55 | |||||
| Price-to-Projected-FCF | 6.98 | |||||
| Price-to-Net-Current-Asset-Value | 2.71 | |||||
| Price-to-Net-Cash | 2.74 | |||||
| Earnings Yield (Greenblatt) % | -15.36 | |||||
| FCF Yield % | -6.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IDEAYA Biosciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 3.596 | ||
| EPS (TTM) (€) | -2.138 | ||
| Beta | -0.01 | ||
| Volatility % | 48.88 | ||
| 14-Day RSI | 42.05 | ||
| 14-Day ATR (€) | 0.576689 | ||
| 20-Day SMA (€) | 26.57 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 24 - 44.4 | ||
| Shares Outstanding (Mil) | 86.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
IDEAYA Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
IDEAYA Biosciences Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
IDEAYA Biosciences Inc Frequently Asked Questions
What is IDEAYA Biosciences Inc(FRA:30J)'s stock price today?
The current price of FRA:30J is €25.40. The 52 week high of FRA:30J is €44.40 and 52 week low is €24.00.
When is next earnings date of IDEAYA Biosciences Inc(FRA:30J)?
The next earnings date of IDEAYA Biosciences Inc(FRA:30J) is 2025-02-20 Est..
Does IDEAYA Biosciences Inc(FRA:30J) pay dividends? If so, how much?
IDEAYA Biosciences Inc(FRA:30J) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers